Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05439291 · ClinicalTrials.gov registry record · NA

Comparing Operative vs Non Operative Treatment for Pilonidal Disease

A NA study of Pilonidal Disease, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT05439291: Recruiting NA study of Pilonidal Disease, sponsored by Stanford University.

NCT05439291 is a NA study of Pilonidal Disease that is actively recruiting participants, run by Stanford University. The registered enrollment target is 400 participants, above the 69-participant average among 5 other Pilonidal Disease trials with a reported enrollment target (480% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05439291, a NA study of Pilonidal Disease, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

The goal is to evaluate whether surgical excision of the pilonidal disease is needed after resolution of the initial symptoms when the patient follows regular hair removal regimen such as laser epilation.

Conditions Studied

Interventions

  • PROCEDURE Regular Epilation Regimen
  • PROCEDURE Surgical excision

Study Locations (1)

California

  • Stanford University School of Medicine - Palo Alto

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2022-07-19
Est. Completion 2027-01
Phase NA
Stanford University

1,744 total trials

What NCT05439291 shows while recruiting

NCT05439291 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 69-participant average among 5 other Pilonidal Disease trials with a reported enrollment target (480% higher).

The record links to 1 condition, with Pilonidal Disease appearing as the primary indexed condition, and to 2 interventions - of which Regular Epilation Regimen is the first listed.

NCT05439291 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05439291 about?

NCT05439291 is a clinical study titled "Comparing Operative vs Non Operative Treatment for Pilonidal Disease". The goal is to evaluate whether surgical excision of the pilonidal disease is needed after resolution of the initial symptoms when the patient follows regular hair removal regimen such as laser epilation.

What is the current status of trial NCT05439291?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2022-07-19. Estimated completion is 2027-01.

What conditions does trial NCT05439291 study?

This clinical trial studies the following conditions: Pilonidal Disease.

What interventions are being tested in trial NCT05439291?

The interventions under investigation include: Regular Epilation Regimen (PROCEDURE), Surgical excision (PROCEDURE).

Who is sponsoring clinical trial NCT05439291?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05439291 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pilonidal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05439291, the US trial registry maintained by the National Library of Medicine. NCT05439291 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.